Altimmune ($ALT) Insider Trading & Smart Money Activity

Altimmune, Inc. · Biotechnology · Latest filing Jun 22, 2026

Altimmune, Inc. ($ALT) has 2 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

2

ALT insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ALT insider, congress, 13F and analyst activity

All Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 22, 2026	Analyst	Leerink Partners	Reiterates to buy		PT $10		+0.3%	-4.1%			Read
Jun 22, 2026	Analyst	Leerink Partners	Reiterates to buy		PT $10		+0.3%	-4.1%			Read

1W / 1M / 6M = how ALT moved from the trade or filing date.

Analyst ratings on ALT

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 22, 2026	Leerink Partners	Reiterates	buy	$10	+0.3%	-4.1%		Read
Jun 22, 2026	Leerink Partners	Reiterates	buy	$10	+0.3%	-4.1%		Read

Other biotechnology stocks

• $MNPR
• $AURA
• $CRMD
• $OABI
• $CBIO
• $PHAT
• $SGMT
• $ZVRA

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.